Marc Blondel
4Patents
1h-index
18Co-inventors
41Inventor score
Filing activity: Oct 20, 2003 → Apr 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7932422B2 | Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases | Human Necessities | 3 | Active |
| US11406631B2 | Hydrazone derivatives for preventing or treating EBV-related cancers | Chemistry; Metallurgy | 0 | Active |
| US8252958B2 | Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells | Human Necessities | 0 | Active |
| US8129402B2 | Screening molecules with anti-prion activity: kits, methods and screened molecules | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.